This inventor holds 4 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Santen Pharmaceutical Co., Ltd.. Active years: 2016-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2021
Title: Kazuhiro Hosoi: Innovator in Ophthalmic Solutions
Introduction
Kazuhiro Hosoi is a notable inventor based in Ikoma, Japan. He has made significant contributions to the field of ophthalmology, particularly through his innovative work on ophthalmic solutions. With a total of 4 patents to his name, Hosoi continues to push the boundaries of medical science.
Latest Patents
One of Hosoi's latest patents focuses on an ophthalmic solution comprising Diquafosol. This invention addresses the formation of insoluble precipitates that can occur during the storage of Diquafosol ophthalmic solutions. It also tackles the deterioration of filtration performance during production. By incorporating a chelating agent at a concentration of 0.0001 to 1% (w/v), the invention has been shown to reduce eye irritation and enhance preservative effectiveness compared to solutions without a chelating agent. The physicochemical properties of this solution have been confirmed to remain stable throughout production, distribution, and patient storage.
Career Highlights
Kazuhiro Hosoi is currently associated with Santen Pharmaceutical Co., Ltd., where he continues to develop innovative solutions for eye care. His work has been instrumental in improving the quality and safety of ophthalmic treatments.
Collaborations
Throughout his career, Hosoi has collaborated with talented individuals such as Tatsuo Ikei and Akiko Sakatani. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Kazuhiro Hosoi is a prominent figure in the field of ophthalmology, with a focus on enhancing the effectiveness and safety of ophthalmic solutions. His innovative patents reflect his commitment to improving patient care and advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
